Early Treatment Helped Seizures In Rare KCNQ2 Deletion

What was studied

This paper is a case report. It describes one girl, age 1 year 5 months, who had seizures starting at 7 days of life and showed severe delays in development. Doctors examined her with EEG, brain MRI, developmental testing, and genetic testing of the child and both parents.

The genetic testing found two copy number changes: a new (de novo) deletion on chromosome 20 that removed the KCNQ2 gene, and a duplication on chromosome 13. The authors concluded that the KCNQ2 deletion was associated with her diagnosis of developmental and epileptic encephalopathy 7 (DEE7). They also used MLPA to confirm the deletion.

What they found

The child had frequent neonatal seizures, abnormal EEG findings, normal brain MRI, and severe early developmental delay. Genetic testing found a large de novo deletion that fully included KCNQ2, which is a known epilepsy gene.

The report states that with early targeted treatment, she became seizure-free and made modest developmental progress. The authors suggest that even with a severe genotype, seizure freedom and some developmental gains may be achievable. They also argue that testing for copy number variants may be important in epilepsy genetic workups.

Limits of the evidence

This is only one patient, so it cannot show what usually happens for other children with the same finding. A case report cannot establish that the treatment caused the good seizure outcome, and it cannot separate the effects of the KCNQ2 deletion from the possible effects of the chromosome 13 duplication.

The abstract does not give much detail about the exact treatment, how long seizure freedom lasted, or how much development improved over time. Because large KCNQ2 deletions are rare, the long-term outlook is still uncertain.

For families and caregivers

For families, this report may offer some cautious hope that seizure freedom can be possible even in a child with a rare and serious KCNQ2-related epilepsy. It also shows why broad genetic testing that can detect missing or extra pieces of chromosomes may matter when a baby has early seizures.

At the same time, this is a single case, so families should not assume the same course for every child. Developmental outcomes can vary, and this report does not answer how much the second chromosome change may have affected the child.

What to watch next

Stronger evidence would come from larger studies of children with KCNQ2 deletions, with clear details on treatments, long-term development, and whether other chromosome changes are also present.

Terms in this summary

DEE7

A severe epilepsy and developmental disorder linked to changes in the KCNQ2 gene.

KCNQ2

A gene that helps make a potassium channel important for normal brain cell signaling.

de novo

A genetic change that is new in the child and was not inherited from either parent.

copy number variant (CNV)

A missing or extra piece of DNA.

heterozygous deletion

A missing piece of DNA on one of the two copies of a chromosome.

EEG

A test that records the brain's electrical activity.

MLPA

A lab test used to confirm missing or extra copies of specific genes or DNA regions.

haploinsufficiency

When having only one working copy of a gene is not enough for normal function.